NTLA 14.3 (+3.62%)
US45826J1051BiotechnologyBiotechnology

Intellia Therapeutics (NTLA) Financial Metrics

This table shows a selected set of financial data points of Intellia Therapeutics (NTLA). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -5.42 0 -5.62 2.71B -0.34 36.28M -408.07M -506.22M -481.19M 226.75M
2022 -6.16 0 -5.66 2.69B -0.34 52.12M -391.68M -437.11M -474.19M 523.51M
2021 -3.78 0 -31.29 8.38B -0.27 33.05M -237.79M -260.96M -267.89M 123.41M
2020 -2.4 0 -22.69 3.05B -0.27 57.99M -53.5M -130.27M -134.23M 160.02M
2019 -2.11 0 -6.96 693.11M -0.29 43.1M -110.03M -100.78M -99.53M 57.23M
2018 -1.98 0 -6.89 587.89M -0.24 30.43M -67.62M -80.88M -85.34M 58.86M
2017 -1.88 0 -10.25 692.04M -0.2 26.12M -75.37M -64.55M -67.54M 340.68M
2016 -1.42 0 -9.21 291.33M -0.17 16.48M 29.94M -30.53M -31.63M 273.06M
2015 -0.7 0 0 0 -0.27 6.04M -4.32M -13.08M -12.4M 75.82M
2014 0 0 0 0 0 0 0 0 -14.31M 9.85M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.